Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (11): 1192-1193.DOI: 10.3969/j.issn.1673-8640.2021.11.021
Previous Articles Next Articles
Received:
2020-10-14
Online:
2021-11-30
Published:
2021-12-20
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.11.021
酵母菌/(个/μL) | 红细胞/(个/μL) | 红细胞形态信息 | 细菌/(个/μL) | 白细胞/(个/μL) | 类酵母菌 |
---|---|---|---|---|---|
102 | 13.00±0.77 | 未提示 | 260.90±4.39 | 7.30±1.12 | - |
103 | 9.20±1.03 | 未提示 | 229.60±4.03 | 34.30±2.74 | - |
104 | 38.40±2.33 | 均一性红细胞 | 433.80±5.06 | 7.90±1.69 | + |
105 | 334.60±6.76 | 均一性红细胞 | 311.90±4.62 | 1.90±0.23 | + |
酵母菌/(个/μL) | 红细胞/(个/μL) | 红细胞形态信息 | 细菌/(个/μL) | 白细胞/(个/μL) | 类酵母菌 |
---|---|---|---|---|---|
102 | 13.00±0.77 | 未提示 | 260.90±4.39 | 7.30±1.12 | - |
103 | 9.20±1.03 | 未提示 | 229.60±4.03 | 34.30±2.74 | - |
104 | 38.40±2.33 | 均一性红细胞 | 433.80±5.06 | 7.90±1.69 | + |
105 | 334.60±6.76 | 均一性红细胞 | 311.90±4.62 | 1.90±0.23 | + |
酵母菌/(个/μL) | 红细胞/(个/μL) | 红细胞形态信息 | 细菌/(个/μL) | 白细胞/(个/μL) | 类酵母菌 |
---|---|---|---|---|---|
102 | 4.70±0.65 | 未提示 | 5.70±1.23 | 5.30±0.64 | - |
103 | 18.80±1.87 | 未提示 | 41.70±3.12 | 23.90±0.53 | - |
104 | 48.30±5.23 | 混合性红细胞 | 30.10±3.23 | 2.80±0.64 | - |
105 | 278.40±5.98 | 混合性红细胞 | 25.50±2.75 | 0.80±0.23 | - |
酵母菌/(个/μL) | 红细胞/(个/μL) | 红细胞形态信息 | 细菌/(个/μL) | 白细胞/(个/μL) | 类酵母菌 |
---|---|---|---|---|---|
102 | 4.70±0.65 | 未提示 | 5.70±1.23 | 5.30±0.64 | - |
103 | 18.80±1.87 | 未提示 | 41.70±3.12 | 23.90±0.53 | - |
104 | 48.30±5.23 | 混合性红细胞 | 30.10±3.23 | 2.80±0.64 | - |
105 | 278.40±5.98 | 混合性红细胞 | 25.50±2.75 | 0.80±0.23 | - |
酵母菌/(个/μL) | 红细胞/(个/μL) | 红细胞形态信息 | 细菌/(个/μL) | 白细胞/(个/μL) | 类酵母菌 |
---|---|---|---|---|---|
102 | 8.40±0.66 | 未提示 | 125.30±4.84 | 6.80±0.84 | - |
103 | 14.50±1.02 | 未提示 | 105.50±4.39 | 4.00±0.88 | - |
104 | 51.70±2.77 | 混合性红细胞 | 88.10±4.01 | 5.50±1.01 | - |
105 | 428.3±6.04 | 混合性红细胞 | 25.50±2.44 | 3.80±0.76 | - |
酵母菌/(个/μL) | 红细胞/(个/μL) | 红细胞形态信息 | 细菌/(个/μL) | 白细胞/(个/μL) | 类酵母菌 |
---|---|---|---|---|---|
102 | 8.40±0.66 | 未提示 | 125.30±4.84 | 6.80±0.84 | - |
103 | 14.50±1.02 | 未提示 | 105.50±4.39 | 4.00±0.88 | - |
104 | 51.70±2.77 | 混合性红细胞 | 88.10±4.01 | 5.50±1.01 | - |
105 | 428.3±6.04 | 混合性红细胞 | 25.50±2.44 | 3.80±0.76 | - |
[1] | 冯玉青, 黄素素, 罗靖, 等. UF-1000i全自动尿液分析仪的细菌通道检测与中段尿培养的符合率分析[J]. 检验医学, 2018, 33(1):60-62. |
[2] | 赵俊红, 马骏龙. UF-100尿沉渣分析仪检测红细胞假阳性结果特征的探讨[J]. 现代检验医学杂志, 2007, 22(1):27-28. |
[3] | 马丽, 袁汉尧, 王小梅. 酵母菌对UF-100全自动尿沉渣分析仪红细胞检测结果的影响[J]. 上海医学检验杂志, 2001, 16(3):161-162. |
[4] | 王春燕, 张淼发. Sysmex UF-100尿沉渣分析仪对尿路感染疗效的监测[J]. 上海医学检验杂志, 2000, 15(2):79-80. |
[5] | 黄松音, 黄雪琼, 谢文锋, 等. 菌尿对两种全自动尿沉渣分析仪检测尿红细胞的影响[J]. 检验医学与临床, 2010, 7(14):1440-1442. |
[6] | 梁朝坤. 浑浊尿液标本在UF-500i分析仪上的应用[J]. 中国卫生产业, 2017, 14(8):53-54. |
[7] | 丛玉隆, 马骏龙, 李云莲, 等. 尿沉渣测定四种方法的参考值范围调查[J]. 中华检验医学杂志, 1997, 20(4):229-231. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||